The Double-Edged Sword How Human Papillomaviruses Interact With Immunity in Head and Neck Cancer

被引：34
作者：
Wang, Hao-fan [1 ]
Wang, Sha-sha [1 ]
Tang, Ya-Jie [2 ]
Chen, Yu [3 ]
Zheng, Min [4 ]
Tang, Ya-ling [3 ]
Liang, Xin-hua [1 ]
机构：
[1] Sichuan Univ, West China Hosp Stomatol, Dept Oral & Maxillofacial Surg, Natl Clin Res Ctr Oral Dis,State Key Lab Oral Dis, Chengdu, Sichuan, Peoples R China
[2] Hubei Univ Technol, Hubei Prov Cooperat Innovat Ctr Ind Fermentat, Hubei Key Lab Ind Microbiol, Minist Educ,Key Lab Fermentat Engn, Wuhan, Hubei, Peoples R China
[3] Sichuan Univ, West China Hosp Stomat, Natl Clin Res Ctr Oral Dis, Dept Oral Pathol,State Key Lab Oral Dis, Chengdu, Sichuan, Peoples R China
[4] Wenzhou Med Univ, Zhoushan Hosp, Dept Stomatobgy, Zhoushan, Peoples R China
来源：
FRONTIERS IN IMMUNOLOGY | 2019年 / 10卷
基金：
中国国家自然科学基金;
关键词：
human papilloma virus (HPV); head and neck squamous cell carcinoma (HNSCC); immune escape; immune responses; immunotherapy; SQUAMOUS-CELL CARCINOMA; TUMOR-INFILTRATING LYMPHOCYTES; HPV-ASSOCIATED HEAD; REGULATORY T-CELLS; LANGERHANS CELLS; CERVICAL-CANCER; PD-L1; EXPRESSION; POSITIVE HEAD; E5; PROTEIN; E7;
D O I：
10.3389/fimmu.2019.00653
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Patients with human papilloma virus (HPV)-associated head and neck squamous cell carcinoma (HNSCC) have remarkably better prognosis, which differs from HPV-negative oropharyngeal squamous cell carcinoma (OPSCC) with respect to clinical, genomic, molecular, and immunological aspects, especially having the characteristics of high levels of immune cell infiltration and high degrees of immunosuppression. This review will summarize immune evasion mechanisms in HPV-positive HNSCC, analyze the host various immune responses to HPV and abundant numbers of infiltrating immune cell, and discuss the differences between HPV-positive HNSCC with cervical cancer. A deeper understanding of the immune landscape will help new concepts to emerge in immune-checkpoint oncology, which might be a valuable add-on to established concepts.
引用
收藏
页数：12
相关论文
共 50 条
  • [31] NF-κB inhibition:: A double-edged sword in cancer?
    Pikarsky, E
    Ben-Neriah, Y
    EUROPEAN JOURNAL OF CANCER, 2006, 42 (06) : 779 - 784
  • [32] FSTL1: A double-edged sword in cancer development
    Du, Ruijuan
    Li, Kai
    Guo, Kelei
    Chen, Zhiguo
    Han, Li
    Bian, Hua
    GENE, 2024, 906
  • [33] Editorial: Cancer therapy: The challenge of handling a double-edged sword
    Nurgali, Kulmira
    Rudd, John A.
    Was, Halina
    Abalo, Raquel
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [34] Macrophages in Glioblastoma Development and Therapy: A Double-Edged Sword
    Wu, Mengwan
    Shi, Ying
    Zhu, Luyi
    Chen, Luoyi
    Zhao, Xinchen
    Xu, Chuan
    LIFE-BASEL, 2022, 12 (08):
  • [35] Zinc Fingers and Homeobox Family in Cancer: A Double-Edged Sword
    Bao, Yonghua
    Zhang, Haifeng
    Han, Zhixue
    Guo, Yongchen
    Yang, Wancai
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (19)
  • [36] A Double-Edged Sword Role of Cytokines in Prostate Cancer Immunotherapy
    Mao, Chenyu
    Ding, Yongfeng
    Xu, Nong
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [37] Clinical utilization of chemokines to combat cancer: the double-edged sword
    Dell'Agnola, Chiara
    Biragyn, Arya
    EXPERT REVIEW OF VACCINES, 2007, 6 (02) : 267 - 283
  • [38] Transcription as a double-edged sword in genome maintenance
    Ouyang, Jian
    FEBS LETTERS, 2025, 599 (02) : 147 - 156
  • [39] Astrocyte in prion disease: a double-edged sword
    Tahir, Waqas
    Thapa, Simrika
    Schatzl, Hermann M.
    NEURAL REGENERATION RESEARCH, 2022, 17 (08) : 1659 - 1665
  • [40] Opioids and Viral Infections: A Double-Edged Sword
    Tahamtan, Alireza
    Tavakoli-Yaraki, Masoumeh
    Mokhtari-Azad, Talat
    Teymoori-Radl, Majid
    Bont, Louis
    Shokri, Faze
    Salimi, Vahid
    FRONTIERS IN MICROBIOLOGY, 2016, 7
12345